Maher Masoud starts as MaxCyte president, CEO

2nd Jan 2024 11:25

(Sharecast News) - MaxCyte confirmed the appointment of Maher Masoud as its new president and chief executive officer on Tuesday, effective from 1 January.

The AIM-traded firm said that alongside his role as CEO, Masoud had joined its board of directors.

With the appointment, MaxCyte was aiming to leverage Masoud's leadership and experience to continue its mission of advancing the field of cell therapeutics and bioprocessing.

At 0813 GMT, shares in MaxCyte were down 0.14% at 352p.

Reporting by Josh White for Sharecast.com.

Top Risers

Share	Price	Change
Ukrproduct (UKR)	2.10	44.55%
Chaarat Gold (CGH)	3.85	39.29%
Fireangel (FA.)	5.75	35.29%
Synairgen (SNG)	7.00	21.53%
Image Scan Holdings (IGE)	1.60	18.52%

Top Fallers

Share	Price	Change
Eqtec (EQT)	1.10	-21.43%
Gfinity (GFIN)	0.03	-16%
Strategic Minerals (SML)	0.165	-15%
Uk Oil & Gas (UKOG)	0.0275	-14.29%
Apq Global (APQ)	6.50	-9.09%

Top By Volume

Share	Price	Volume
Supply@me Cap (SYME)	0.02	1,661,102,421
Mosman Oil Gas (MSMN)	0.022	239,666,153
Lloyds (LLOY)	55.52	207,519,217
Clontarf (CLON)	0.0475	181,070,205
Beacon Energy. (BCE)	0.0575	128,296,205

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.